Kynurenine as a potential biomarker in detecting reduced muscle endurance: metabolomic profiling of patients with heart failure and exercise intolerance
Tarek Bekfani(University Hospital Magdeburg), P. Christian Schulze(Temple College), Tom Kretzschmar(Jena University Hospital), Mohamed M. Bekhite(Jena University Hospital), Marcus Franz(Jena University Hospital), Ali Hamadanchi(Friedrich Schiller University Jena), Stephan von Haehling(German Centre for Cardiovascular Research), Ruediger C. Braun‐Dullaeus(University Hospital Magdeburg), Michael Kiehntopf(Jena University Hospital), Steffen Derlien(Friedrich Schiller University Jena), Michael Lichtenauer(University of Salzburg), M.F Wu(Jena University Hospital), Sophie Neugebauer(Jena University Hospital), Sven Moebius‐Winkler(Jena University Hospital), Daniela Haase(Schiller International University)
Cited by 0
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767